Dual blockade of CD73-TGFβ has led to promote a complex inflammatory tumor microenvironment, characterized by decreased levels of myeloid-derived suppressor cells (MDSCs) and M2-macrophages, as well as increased levels of activated dendritic cells, cytotoxic T cells, and B cells (33). The gene discussed is TGFB1; the disease is neoplasm.